7:18 PM ET
Earnings Call
▶ Call
Personalis Earnings Call: Key Takeaways
Personalis presented interim Victory study data for NeXT Personal, demonstrating 96% pre-surgical sensitivity and 100% detection of colorectal cancer recurrences with significant lead-time advantages.